Embryotoxicity screening using embryonic stem cells in vitro: Correlation to in vivo teratogenicity

Cells Tissues Organs

Volumn 165, Issue 3-4, 1999, Pages 203-211

  Scholz, Gabriele ^a,c   Pohl, Ingeborg ^a   Genschow, Elke ^b   Klemm, Martina ^a   Spielmann, Horst ^a  

^a BgVV   (Germany)

^b Fed Inst Hlth Protect C   (Germany)

^c FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Cardiomyocytes; Cytotoxicity; Differentiation in vitro; Embryonic stem cell test; Embryotoxicity; Prediction model

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ASCORBIC ACID; CAFFEINE; CENTRAL STIMULANT AGENT; CYTARABINE; CYTOSTATIC AGENT; DEXAMETHASONE; FLUOROURACIL; GLUCOCORTICOID; HYDROXYUREA; ISONIAZID; PENICILLIN G; PHENYTOIN; RETINOIC ACID; VITAMIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG EXPOSURE; EMBRYO CELL; EMBRYOTOXICITY; HEART MUSCLE CELL; HUMAN; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL MODEL; STEM CELL; TERATOGENICITY;

ANIMALIA;

EID: 0032745067     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016700     Document Type: Article

References (39)

1. Anon (1981) OECD Guideline for Testing of Chemicals. No 414: Teratogenicity. Paris, Organisation for Economic Co-Operation and Development.
2. Anon (1983) OECD Guideline for Testing of Chemicals, No 415: One Generation Reproduction Toxicity Study. Paris, Organisation for Economic Co-Operation and Development.
3. Anon (1983) OECD Guideline for Testing of Chemicals, No 416: Two Generation Reproduction Toxicity Study. Paris, Organisation for Economic Co-Opcration and Development.
4. Anon (1995) OECD Guideline for Testing of Chemicals, Draft Guideline No 421: Reproduction/Developmental Toxicity Screening Test. Paris, Organisation for Economic Co-Operation and Development.
5. Anon (1996) OECD Guideline for Testing of Chemicals, Draft Guideline No 422: Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test. Paris, Organisation for Economic Co-Operation and Development.
6. Backhaus, K., B. Erichson, W. Plinke, R. Weiber (1996) Multivariate Analysemethoden, ed 8. Berlin, Springer.
7. Balls, M., B.J. Blaauboer, D. Brusick, J. Frazier, D. Lamb, M. Pemberton, C.A. Reinhardt, M. Roberfroid, H. Rosenkranz, B. Schmid, H. Spielmann, A.-L. Stammati, E. Walum (1990) Report and recommendations of the CAAT/ER-GATT Workshop on the Validation of Toxicity Test Procedures. ATLA 18: 313-337.
8. Balls, M., B.J. Blaauboer, J.H. Fentem, L. Bruner, R.D. Combes, B. Ekwall, R.J. Fielder, A. Guillouzo, R.W. Lewis, D.P. Lovell, C.A. Reinhardt, G. Repetto, D. Sladowski, H. Spielmann, F. Zucco (1995) Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM Workshop 5. ATLA 23: 129-147.
9. Bortz, J. (1993) Statistik, ed 3. Berlin, Springer.
10. Brown, N.A., H. Spielmann, R. Bechter, O.P. Flint, S.J. Freeman, R.J. Jelinek, E. Koch, H. Nau, D.R. Newall, A.K. Palmer, J.-Y. Renault, M. Repetto, R. Vogel, R. Wiger (1995) Screening chemicals for reproductive toxicity: The current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM workshop 12). ATLA 23: 868-882.
11. Curren, R.D., J.A. Southee, H. Spielmann, M. Liebsch, J.H. Fentem, M. Balls (1995) The role of prevalidation in the development, validation and acceptance of alternative methods (the first report of the ECVAM Task Force on Prevalidation). ATLA 23: 211-217.
12. Doetschman, T., H.R. Eistetter, M. Katz, W. Schmidt, R. Kemler (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27-45.
13. Evans, M.J., M.H. Kaufman (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
14. Flint, O.P., T.C. Orton (1984) An in vitro assay for teratogens with cultures of rat embryo mid-brain and limb cells. Toxicol Appl Pharmacol 76: 383-395.
15. Genschow, E., G. Scholz, N.A. Brown, A.H. Piersma, M. Brady, N. Clemann, H. Huuskonen, F. Paillard, S. Bremer, H. Spielmann (199J) Die Entwicklung von Prädiktionsmodellen für drei in vitro Embryotoxizitätstests in Rahmen einer ECVAM Validierungsstudie. ALTEX 16: 73-83.
16. Heuer, J., I.M. Graeber, I. Pohl, H. Spie mann (1994) Culture system for the differentiation of murine embryonic stem cells - A new approach to in vitro testing for embryotoxicity aid for developmental immunotoxicology; in Fracchia GN (ed): European Medicines Research. Amsterdam, IOS Press, pp 134-145.
17. ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use (1993) ICH Harmonised Tripartite Guideline: Detection of Toxicity to Human Reproduction for Medicinal Products. Recommended for Adoption at Step 4 of the ICH Process on 24 July 1993 by the ICH Steering Committee. Geneva, ICH Secretariat.
18. Kochhar, D.M. (1997) Retinoids; in Kavlock, R.J., G.P. Daston (eds): Handbook of Experimental Pharmacology, vol 124/II: Drug Toxicity in Embryonic Development. Berlin, Springer, pp 13-29.
19. Kolossov E., B.K. Fleischmann, Q. Liu, W. Bloch, S. Viatchenko-Karpinski, O. Manzke, G.J. Ji, H. Bohlen, K. Addicks, J. Hescheler (1998) Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 143: 2045-2056.
20. Laschinski, G., R. Vogel, H. Spielmann (1991) Cytotoxity test using blastocyst-derived euploid embryonal stem cells: A new approach to in vitro teratogenesis screening. Reproc Toxicol 5: 57-64.
21. Maltsev, V.A., J. Rohwedel, J. Hescheler, A. Wobus (1993) Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44: 41-50.
22. Maltsev, V.A., A.M. Wobus, J. Rohwedel, M. Bader, J. Hescheler (1994) Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75: 233-244.
23. Metzger, J.M., W.I. Lin, L.C. Samuelson (1996) Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. Circ Res 78: 547-552.
24. Newell, D.R., K.E. Beedles (1994) The stem cell test - A novel in vitro assay for teratogenic potential. Toxicol In Vitro 8: 697-701.
25. Norušis, M.J. (1994) SPSS Professional Statistics™ 6.1. Chicago, SPSS.
26. Rohwedel, J., K. Guan, A.M. Wobus (1999) Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 165: 190-202.
27. Rohwedel, J., V.A. Maltsev, E. Bober, H.-H. Arnold, J. Hescheler, A.M. Wobus (1994) Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 164: 87-102.
28. Scholz, G., E. Genschow, I. Pohl, S. Bremer, M. Paparella, H. Raabe, F. Moldenhauer, J. Southee, H. Spielmann (1999) Prevalidation of the embryonic stem cell test (EST), a new in vitro embryotoxicity test. Toxicology In Vitro 13: 675-681.
29. Scholz, G., I. Pohl, A. Seiler, S. Bremer, N.A. Brown, A.H. Piersma, H.G.H. Holzhütter, H. Spielmann (1998) Ergebnisse der ersten Phase des ECVAM Projektes zur Prävalidierung und Validierung von drei in vitro Embryotoxizitätstests. ALTEX 15: 3-8.
30. Smith, M.K., G.L. Kimmel, D.M. Kochhar, S.P. Shepard, S.P. Spielberg, J.G. Wilson (1983) A selection of candidate compounds for in vitro teratogenesis test validation. Teratogenesis Carcinogenesis Mutagenesis 3: 461-480.
31. Southee, J.A., R.D. Curren (1997) A prevalidation process. Comments Toxicol 6: 27-35.
32. Spielmann, H. (1998) Reproduction and development. Environ Health Perspect 106: 571-576.
33. Spielmann, H., I. Pohl, B. Döring, M. Liebsch, F. Moldenhauer (1997) The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In vitro Toxicol 10: 119-127.
34. Strübing, C., G. Ahnert-Hilger, S. Jin, B. Wiedenmann, J. Hescheler, A.M. Wobus (1995) Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech Dev. 53: 1-13.
35. Thomas, K.R., M.R. Capecchi (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512.
36. Wiles, M.V. (1993) Embryonic stem cell differentiation in vitro. Methods Enzymol 225: 900-917.
37. Wiles, M.V., G. Keller (1991) Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111: 259-267.
38. Williams, R.L., D.J. Hilton, S. Pease, T.A. Willson, C.L. Stewart, D.P. Gearing, E.F. Wagner, D. Metcalf, N.A. Nicola, N.M. Gough (1988) Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687.
39. 2+ channel blockers. Differentiation 48: 173-182.